Skip to Main Content

Training Available: CAR T-Cell Therapy

Date: 07/20/20

Envolve Pharmacy Solutions (EPS) recently released educational material for providers regarding chimeric antigen receptor (CAR) T-cell therapy.

CAR T-cell therapy is a type of adoptive immunotherapy that uses a patient’s own modified white blood cells (T-cells) to target and eliminate cancerous cells.

Highlights of this training include:

  • Definition of CAR T-cell therapy
  • Review of CAR T-cell treatment phases
  • Identification of major toxicities associated with the therapy
  • Discussion of FDA approved treatments and key clinical studies
  • Presentation of the Institute for Clinical and Economic Review (ICER) evaluation

Access the CAR T-Cell Therapy Training (PDF).

This training was reviewed at the Q3 2020 meeting of the Louisiana Healthcare Connections Pharmacy and Therapeutics (P&T) Committee.